ON’S Successful Executive Placements in H1 2021

Jul 29, 2021

ON Partners placements across life sciences and healthcare sectors continue to rise in the first half of 2021

During the first half of 2021, ON Partners consultants made high-level executive life sciences and healthcare placements across a wide range of organizations, including Apton Bio, Bionano Genomics, Siemens, and Thermo Fisher.

The practice saw 49% growth over the past year, and for the second year in a row, ON Partners was ranked by Hunt Scanlon in its Top 50 Healthcare and Life Sciences Search Firms. The demand for ON’s life sciences and healthcare executive search services has contributed to the firm’s overall 89.3% growth over the previous three-year period.

“Whether it’s attributed to pent-up demand post-COVID or a strong market driving IPO activity and venture/PE dollars into life sciences, the demand for talent is unprecedented right now. One client likened it to the dotcom frenzy in 2000,” noted partner Steve Cornacchia. “We’re seeing many candidates with multiple job offers even if they were initially passive when first approached, and we’re counseling clients to move fast and feel comfortable landing a candidate sooner than they may usually have planned to make a decision on the candidate pool.”

Added partner Suzanne Zebedee, “Companies are working to retain employees through stock and RSU packages while making sure their base and bonus plans are in line with external compensation data, which is substantially on the rise due to the hot market and the demand for talent.”


Highlights of ON life sciences and healthcare placements during the first half of 2021 include:

Apton Biosystems – CEO

Apton Biosystems has re-imagined the optical systems for sequencing and single molecule detection using super-resolution to evaluate molecules spaced closer than a wavelength of light.

Artisan Biopharma – Vice President, Business Development

Artisan Biopharma is a for-profit public benefit corporation owned entirely by the Children’s Cancer Therapy Development Institute (cc-TDI). We are the connection for moving breakthrough research and development at cc-TDI into transformative clinical trials. Our mission is to provide research-driven interventions for the treatment and prevention of cancer in children.

Bionano Genomics – Chief Commercial Officer

Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. Bionano’s Saphyr system is a research use only platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics.

CytomX – Vice President, Business Development

CytomX is a clinical-stage, oncology-focused biopharmaceutical company with a vision of transforming lives with safer, more effective therapies. We are developing a novel class of investigational conditionally activated therapeutics, based on our Probody® technology platform, for the treatment of cancer. CytomX has strategic drug discovery and development collaborations with AbbVie, Amgen, Astellas, and Bristol Myers Squibb.

IGM Biosciences – Chief Business Officer, Chief Commercial Officer

Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

Nautilus Biotechnology – Vice President, Research and Development, Life Sciences

Nautilus Biotechnology seeks to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. By integrating breakthrough innovations in computer science, engineering, and biochemistry we have designed a large-scale, single molecule proteomic analysis technology capable of delivering extreme sensitivity and scale.

Siemens Healthineers– VP R&D Operations

Siemens AG is a German multinational conglomerate corporation headquartered in Munich and the largest industrial manufacturing company in Europe with branch offices abroad.

Thermo Fisher Scientific  – VP Innovation, VP Supply Chain

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue exceeding $30 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

We believe a better executive search experience matters, and that experience starts with expert, tenured specialists. We’ve been serving the healthcare and life sciences sector since our inception in 2006. Our expert consultants bring substantial recruiting and operating experience with a solid understanding of what creates successful, effective leaders in this highly regulated and demanding scientific space. Learn more about ON’s life sciences and healthcare executive search services here.

Follow our work, updates, and recent success on Twitter and LinkedIn.

Find our related successful placements of leading executives here.

About ON Partners

Since 2006, ON Partners is the only pure-play executive search firm building diverse C-level and board leadership teams. We rebuilt the institution of executive search for the way you work. Our approach includes present partners who engage with their clients from the first brief to the final decision, individually crafted solutions that are unique to each client, and an easier experience all around. Named by Forbes as one of America’s Best Executive Recruiting Firms and to the Inc. 500/5000 Lists nine times, ON Partners is consistently ranked among the top 20 retained executive search firms in the U.S.

Untraditional by Choice. Original by Design. Since 2006.


If you want to create a new path – ON Partners knows how to help you get there.